Your browser doesn't support javascript.
loading
Authors' reply: PSMA-PET: is the time to say goodbye to metabolic radiopharmaceuticals in prostate cancer?
Alberts, Ian; Seide, Svenja Elizabeth; Mingels, Clemens; Bohn, Karl Peter; Shi, Kuangyu; Zacho, Helle D; Rominger, Axel; Afshar-Oromieh, Ali.
Afiliação
  • Alberts I; Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, CH-3010, Bern, Switzerland. ian.alberts@insel.ch.
  • Seide SE; Institute of Medical Biometry and Informatics, University of Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.
  • Mingels C; Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, CH-3010, Bern, Switzerland.
  • Bohn KP; Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, CH-3010, Bern, Switzerland.
  • Shi K; Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, CH-3010, Bern, Switzerland.
  • Zacho HD; Department of Nuclear Medicine and Clinical Cancer Research Center, Aalborg University Hospital, Hobrovej 18-22, DK-9000, Aalborg, Denmark.
  • Rominger A; Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, CH-3010, Bern, Switzerland.
  • Afshar-Oromieh A; Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, CH-3010, Bern, Switzerland.
Eur J Nucl Med Mol Imaging ; 48(8): 2307-2308, 2021 07.
Article em En | MEDLINE | ID: mdl-33948676
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Compostos Radiofarmacêuticos Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Compostos Radiofarmacêuticos Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article